Kabra Drugs informs about compliance certificate

08 Apr 2022 Evaluate
Kabra Drugs has informed that it enclosed a copy of the Certificate dated April 5, 2022 received from Skyline Financial Services, the Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

28.52 -1.39 (-4.65%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×